You just read:

Theravance Biopharma Announces Positive Top-Line Results from Phase 2b Study of Velusetrag (TD-5108) in Patients with Gastroparesis

News provided by

Theravance Biopharma, Inc.

Aug 02, 2017, 07:00 ET